SCHEMBL7301168

SCHEMBL7301168

CCCCCCCCCCCCC(O)c1coc([Si](C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.40
LTB4R Q15722 4/20 0.36
ADRB2 P07550 4/20 0.36
S1PR2 O95136 1/20 0.34
S1PR1 P21453 1/20 0.34
S1PR3 Q99500 1/20 0.34
LPAR2 Q9HBW0 1/20 0.34
PTGER2 P43116 1/20 0.34
GPR84 Q9NQS5 3/20 0.33
MAPK1 P28482 2/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
SPHK1 Q9NYA1 1/20 0.33
FFAR1 O14842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9671527 1.00 CA2 (0.40) CA2LTB4RADRB2S1PR2S1PR1
SCHEMBL9671129 1.00 CA2 (0.40) CA2LTB4RADRB2S1PR2S1PR1
SCHEMBL7303995 1.00 CA2 (0.40) CA2LTB4RADRB2S1PR2S1PR1
Cyclohexane SCHEMBL10651191 0.94 CA2 (0.36) CA2LTB4RADRB2PTGER2MAPK1
SCHEMBL9670027 0.93 ADRB2 (0.36) CA2LTB4RADRB2ALDH1A1
SCHEMBL7293488 0.88 CA2 (0.39) CA2LTB4RADRB2S1PR2S1PR1
SCHEMBL7295098 0.86 SPHK1 (0.38) CA2ADRB2GPR84TP53CYP1A2
SCHEMBL9734634 0.82 LTB4R (0.44) LTB4RPTGER2FFAR1ALDH1A1
SCHEMBL9744900 0.80
SCHEMBL9671433 0.80 FAAH (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5171863-A 2-trialkylsily-4-substituted furan derivatives ALLERGAN, INC. (US) 1992-12-15 US claimed
US-5376676-A Process of using anti-inflammatory furanones as selective calcium channel inhibitors ALLERGAN, INC. (US) 1994-12-27 US disclosed
US-5322953-A Antiinflammatory agents; intermediates for 2-furanone compounds ALLERGAN, INC. (US) 1994-06-21 US disclosed
US-5298633-A Silane intermediates ALLERGAN, INC. (US) 1994-03-29 US disclosed
US-5171863-A 2-trialkylsily-4-substituted furan derivatives ALLERGAN, INC. (US) 1992-12-15 US disclosed
EP-0295056-B1 ANTI-INFLAMMATORY FURANONES ALLERGAN, INC (US) 1992-08-05 EP disclosed
US-5134128-A Immunosuppressive and antiproliferative activity for psoriasis and calcium homeostasis ALLERGAN, INC. (US) 1992-07-28 US disclosed
US-5089485-A ANTI-INFLAMMATORY FURANONES ALLERGAN, INC. (US) 1992-02-18 US disclosed
US-5082954-A Intermediates and processes for preparing 4-substituted 2-5(H)-furanones as anti-inflammatory agents ALLERGAN, INC. (US) 1992-01-21 US disclosed
US-5045564-A Calcium channel antagonists ALLERGAN, INC. (US) 1991-09-03 US disclosed
US-5013850-A 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents ALLERGAN, INC. (US) 1991-05-07 US disclosed
EP-0372940-A2 Anti-inflammatory 2-furanones ALLERGAN, INC (US) 1990-06-13 EP disclosed
EP-0369811-A2 Anti-inflammatory furanones ALLERGAN, INC (US) 1990-05-23 EP disclosed
EP-0295056-A1 Anti-inflammatory furanones ALLERGAN, INC (US) 1988-12-14 EP disclosed